Insulet
PODD
#1094
Rank
A$30.71 B
Marketcap
A$436.33
Share price
-0.95%
Change (1 day)
4.79%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2025 (TTM): A$0.56 Billion

According to Insulet's latest financial reports the company's current earnings are A$2.52 Billion. In 2024 the company made an earning of A$0.51 Billion, an increase over its 2023 earnings that were of A$0.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.56 B9.4%
2024 A$0.51 B36.76%
2023 A$0.37 B481.9%
2022 A$65.13 M-45.24%
2021 A$0.11 B43.35%
2020 A$82.96 M18.51%
2019 A$70 M41.16%
2018 A$49.59 M-711.95%
2017 -A$8.11 Million-56.85%
2016 -A$18.79 Million-79.31%
2015 -A$90.81 Million63.85%
2014 -A$55.42 Million31.04%
2013 -A$42.3 Million-21.96%
2012 -A$54.2 Million
2010 -A$51.69 Million-42.38%
2009 -A$89.71 Million-33.56%
2008 -A$0.14 Billion65.93%
2007 -A$81.37 Million209.75%
2006 -A$26.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ICU Medical
ICUI
A$0.18 B-65.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-A$0.31 Billion-156.35%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
A$1.47 B 168.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.95 B 8,807.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$12.29 B 2,137.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$9.68 B 1,662.44%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$34.00 B 6,087.41%๐Ÿ‡บ๐Ÿ‡ธ USA